Research participant's arm in a machine designed for motor impairment study

Motor Impairment

RESEARCH CENTRE

Staff, students, visitors and colleagues

A number of staff at NeuRA are part of the core of the Program.
This includes:
Dr Annie BUTLER (a.butler@neura.edu.au)
Dr Martin HÉROUX (m.heroux@neura.edu.au)
Dr Phu HOANG (p.hoang@neura.edu.au)
Dr Jasmine MENANT (j.menant@neura.edu.au)
Dr Daina STURNIEKS (d.sturnieks@neura.edu.au)

A number of doctoral and other students are part of the Program.
This includes:
Joana CAETANO (j.caetano@neura.edu.au)
Siobhan FITZPATRICK (s.fitzpatrick@neura.edu.au)
David KENNEDY (d.kennedy@neura.edu.au)
James MCLAUGHLIN (james.mcloughlin@flinders.edu.au)
James NUZZO (j.nuzzo@neura.edu.au)
Daniel SCHOENE (d.schoene@neura.edu.au)
Trinidad VALENZUELA (t.valenzuela@neura.edu.au)

We are also being joined by a number of key visitors, collaborators and other contributors.
This includes:
Bart BOLSTERLEE, PhD student from the Faculty of Mechanical, Maritime and Materials Engineering, Delft University of Technology, Netherlands (to April 2014)
Joanna DIONG, Lecturer, University of Sydney (January 2014 on)
Andreas EJUPI, PhD student from Austrian University of Technology, Austria (January to May 2014)
Graham KERR, Professor, Queensland University of Technology, Brisbane, Australia (January 2014 on)
Yves GSCHWIND, post-doctoral researcher from University Hospital Basel and University of Basel, Switzerland (January to October 2014)
Hiske VAN DUINEN, post-doctoral researcher from the Karolinska Institute, Stockholm, Sweden (January to March 2014)
Leah BENT, Associate Professor at the University of Guelph, Canada (February to June 2014)

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

LEAD!- Leveraging Evidence into Action on Dementia

Currently, there is no effective treatment for dementia, highlighting the urgent need to preventing more cases through evidence-based strategies for risk reduction. As there is an overlap between the risk factors for dementia and other preventable non-communicable diseases including stroke, diabetes, and heart disease, it is important to build upon proven risk-reduction strategies. What is LEAD? LEAD! is a project funded by the NHMRC Boosting Dementia Research Grant led by Professor Kaarin Anstey. It involves an international collaboration between leading academics, clinicians, consumers, and community members. Organisations involved include the Department of Health, WHO, Dementia Australia, Alzheimer’s Disease International, Diabetes Australia, and Heart Foundation. The project aims to translate dementia research and implement evidence-based strategies for dementia risk reduction to individuals, communities, and healthcare centres. Three workstreams The project has three concurrent workstreams over five years: Development, Implementation, and Evaluation and adoption. The Development stream, led by Professor Kaarin Anstey and Associate Professor Peters, focuses on building a new tool for predicting dementia and other non-communicable diseases including stroke, diabetes or myocardial infarction. The tool will be available to the public, researchers and clinicians. It will save clinical assessment time, accurately predict multiple outcomes and will be more acceptable in comparison to using individual tools for each disease outcome. The Implementation stream led by Professor Nicola Lautenschalger’s team at the University of Melbourne, will develop strategies to support the implementation of dementia risk reduction evidence by engaging with consumers, clinicians, policy makers, and the public. The stream will develop strategies for incorporating the new risk assessment tool into various technological platforms (e.g., websites or apps). The Evaluation and adoption stream, led by Professor Anstey and in collaboration with Professor Louisa Jorm and Dr Heidi Welberry at UNSW, focuses on measuring trajectories of Australian’s national risk factor profiles for multiple chronic diseases. Collaboration with key stakeholders including the WHO will help build an evaluation framework and methodology for implementing evidence on dementia risk reduction based on WHO guidelines at national level and in the global context.
PROJECT